Northwestern has formed the Center for Translational Pain Research, which aims to advance basic and clinical science in the hopes of developing non-addictive treatments for chronic pain.
Joel Voss, PhD, and John Disterhoft, PhD, have received a $6.3 million grant from the NIH as part of the BRAIN Initiative.
Talia Lerner, PhD, has received the NIH Director’s New Innovator Award, an early-career grant supporting projects in the biomedical, behavioral or social sciences.
A molecule drastically reduced toxic proteins in human neuron cells with Huntington’s disease, representing a potential therapy for the deadly degenerative disease, according to a new study.
Northwestern Medicine scientists have discovered that the protein FMRP — the loss of which leads to Fragile X syndrome — is a novel reader of RNA methylation.
A new study published in Developmental Cell discovered a link between a previously unknown mitochondrial process and Charcot-Marie-Tooth disease Type 2, a genetic neuropathy.
With advances in technology and genetics, Feinberg and Northwestern investigators are conducting basic science research to understand just how the retina works in concert with the brain.
A recent study revealed how sensory processing centers communicate with one another within brain, with implications for neurodegenerative disease.
Northwestern Medicine scientists have mapped a brain circuit that sends information from the hippocampus and thalamus to the retrosplenial cortex, an area of the brain involved in memory formation.
According to a recent study, a novel nanoparticle-based drug repaired neurons and improved microvasculature in a mouse model of spinocerebellar ataxia 1, a degenerative disease that affects the cerebellum.